The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”-Reference-Cited by-同舟云学术

The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”

Published:2020-08 Issue:4 Volume:3 Page:412-419
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Ali Adnan^ORCID,Hoyle Alex P.,Parker Christopher C.,Brawley Christopher D.,Cook Adrian,Amos Claire,Calvert Joanna,Douis Hassan,Mason Malcolm D.,Attard Gerhardt,Parmar Mahesh K.B.,Sydes Matthew R.^ORCID,James Nicholas D.,Clarke Noel W.

Funder

Cancer Research UK

Medical Research Council

National Institute for Health Research (NIHR) Biomedical Research Centre

Institute of Cancer Research

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference25 articles.

1. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer;Ali;BJU Int,2019

2. Quantification of skeletal metastases in castrate-resistant prostate cancer predicts progression-free and overall survival;Tait;BJU Int,2014